Just-sold.co.uk – Online auction platform launched


99home
 launches just-sold.co.uk – a modern way of selling property via digital auction and secure sales method. Digital Auction Platform Easy, Secure and Guaranteed way of buying and selling property online across the UK and Europe. A B2B2C platform 99home, the UK’s 5th largest online estate agents has taken a big step forward by entering into digital property auction services. just-sold.co.uk is the combination of technology and marketing exposure which gives the perfect balance to sell the property fast and at a genuine price. The co-founder of 99home Sachinkumar Gupta, member of National Association of Valuer and Auctioneer (NAVA) will ascertain that the process and transparency will be taken care during the entire practice and operation of just-sold.co.uk 

A few key features: 

● 0% fee to sell your property, nothing hidden

● Free auction service for the Vendors and agents

● No catch and fully transparent

● Instant buy, reserve, sell via auction or secure method

● Bidding available 24 hours a day, 7 days a week

● Swift and Secure

● Competitive bidding, no middle man hassle

● Estate Agents can use without sharing commission*

● FREE legal pack option for the vendor/agents 

99home, One Stop Property Shop, deals in residential and commercial property sales, lettings, property management, mortgages and conveyancing will now have access to the in-house auction facilities. 99home has been recognized World top “30 Fabulous company of the year” by US-based magazine Silicon Review, “Online Estate Agent of the Year” by London wire, “Most Trusted Agent of The Year” by the Build magazine, “UK’s Most Innovative Online Real Estate Agency of the Year” by CV Magazine, and ‘’ Online Estate Agents of the Year’’ by the London Prestige Awards 2019/20. Sachin Gupta (BSc., MNAVA, MARLA, MNAEA) – Co-founder and CEO of 99home believes that the modern method of selling properties will touch the 100K mark this year vs around 50K in 2019, especially, when agents and a vendor do not have to share the commission. 

Vijay Vashistha – Co-founder and CTO of 99home designed and developed this solution in-house offering fixed fees option pertransaction based on No Success No Fees.

COVID-19 has changed the complete industry outlook, he strongly believes digital method will be the solution and the ideal method going forward. 

Truly, Vijay VashisthaCo-founder of 99home.co.uk

Appointment of Chandra Shukla as Senator for World Business Angle Investment Forum

India is now more connected with global investment markets As announced by the World Business Angels Investment Forum, Chandra Shukla, Advisory Council Member of the Harvard Business Review & Vice President at TD, has been appointed as Senator for India.

Senator Shukla to represent India at the Grand Assembly of the World Business Angels Investment Forum. The inclusion of India in WBAF provides a wide range of opportunities for India’s start-ups, scaleups and high growth businesses and opens doors for economic development.

(London) With this new appointment, India has joined the largest forum of the world’s equity investment markets and will now be able to connect more with the global investors market, which will open up splendid opportunities for the country. Now local India angel investors, incubation centres, accelerators, private equity funds, co-investment funds, technology parks, corporate ventures and aspiring entrepreneurs will have more opportunity to connect with global leaders in the same field.

The inclusion of India in WBAF provides a wide range of opportunities for India’s start-ups, scaleups and high growth businesses and opens doors for economic development.

Baybars Altuntas, Chairman of the Board of Directors of the World Business Angels Investment Forum says “As an affiliated partner of the G20 Global Partnerships for Financial Inclusion (GPFI), the WBAF supports start-ups, develops entrepreneurial ecosystems, and helps venture capital and companies connect with international companies, fin-techs and other relevant institutions. We are confident about our contribution to the economic development of the country by facilitating connections with entrepreneurial ecosystems. We strongly believe that India will soon become a country that can foster the development of its economy in a more entrepreneurial atmosphere.”

About the World Business Angels Investment Forum (WBAF) As an affiliated partner of the G20 Global Partnership for Financial Inclusion (GPFI), the World Business Angels Investment Forum (WBAF) is committed to collaborating globally to empower the economic development of the world by fostering innovative financial instruments for startups, scaleups, innovators, entrepreneurs and SMEs and to promoting gender equality and women’s participation in all sectors of the world economy. WBAF invites you to join our global efforts to ease access to finance, promote financial inclusion, and create more jobs and social justice.

WBAF accomplishes its mission through various parties and channels. These include: 138 high commissioners, senators and international partners from 79 countries; 7 country offices on 5 continents; the WBAF Business School and its more than 50 faculty members from 32 countries; and 5 international working committees. WBAF also has an angel investment fund, partnerships with 12 global institutions, and economic cooperation agreements with 5 governments. The WBAF World Congress, held in February of each year, hosts at least 5 summits and numerous other events, including a Global Fundraising Stage and a World Excellence Awards ceremony. WBAF also boasts a number of publications, among which are the WBAF Business School Journal, World Class Startup Magazine, and Angel Investor Review Online.

www.wbaforum.org About GPFI The Global Partnership for Financial Inclusion (GPFI) is an inclusive platform for all G20 countries, interested non-G20 countries, and relevant stakeholders to carry forward work on financial inclusion, including implementation of the G20 Financial Inclusion Action Plan endorsed at the G20 Summit in Seoul. Queen Maxima of the Netherlands is the Honorary Patron of the GPFI.

www.gpfi.org

About Chandra Shukla

Chandra is passionate about Artificial Intelligence, Machine Learning, Mathematics, and creating solutions to real-life challenges utilizing all these. He is a sought-after expert in the domain. He is often invited to high-profile conferences like Open Data Science Conference, Chief Data and Analytics Conference, and Ai4Finance conference, to name a few.

He is currently affiliated with the Advanced Analytics Team at TD Bank, New York. While in India, he worked for a short stint at Jameel Poverty Action Lab (J PAL) on randomized control trial whose principal investigator was Prof Abhijeet Banerjee (Noble Prize 2019).

He is a recipient of the prestigious Data Science for Social Good Fellowship.

During his grad school, he designed an AI-powered business process (patent pending) to sell the eBooks at a price chosen by the users. The initial prototype is available at www.personalizedprice.com. He is also the father of the problem-solving website www.mypressingproblem.com which is utilizing Artificial Intelligence and advanced Machine Learning techniques to empower people solving their problems.

In addition to being at the forefront of the technical domain, he has occupied several leadership positions as well. He is a Board member of the Michigan Engineering Alumni Board and IIT BHU Global Alumni Association. He has also held multiple board positions while in grad school, including the Vice President of the Industrial and Operations Engineering Leadership Board at the University of Michigan. He has featured in Marquis Who’s Who in America, Who’s Who in the World, and Who’s Who Top Executive.

He is also a chartered member of The Indus Entrepreneurs (TiE) New York chapter. Linkedin: http://www.linkedin.com/in/shuklachan

TEAM Telecom Armenia official statement

On July 3rd a totally misleading article misrepresenting the reality was published on https://release-news.com/VEON is about to sell the Armenian branch to people, who have been involved in the corruption deals in Armenia.

In this regard, TEAM Telecom Armenia announces that its co-founders Hayk and Alex Yesayans have no any connection to G. Kachatryan’s criminal case and have never had any involvement in any other criminal proceedings.
Moreover, over a year Hayk and Alex Yesayans had disagreements with the Khachatryan family around the Ucom management as a result of which Hayk Yesayan applied for resignation followed by a similar action of the management and technical staff not willing to work with the new management.


TEAM Telecom Armenia which has been recently registered officially, after a successful conclusion of Veon acquisition deal, will create a new generation network Veon Armenia’s capabilities with the robust Veon team.


TEAM has already signed a memorandum with Ericsson on the development and modernization of the mobile network, design of a new data center, as well as started building NGN network, which will be the first one in the region.


So far, a lot of physical and legal entities have already expressed their desire to switch to the new operator network and use its services.

$500 million dollar lawsuit filed against USA Today and Gannett

Vivera Pharmaceuticals today filed a lawsuit in Federal Court against Gannett, its publication USA Today, and their reporters and executives for damages in excess of $500 million for defamation, trade libel and intentional and negligent interference with prospective economic advantage.

On June 2, 2020, USA Today reporters David Heath, Kevin McCoy and Donovan Slack, published an article entitled “You could see the train wreck coming’: Inexperienced, dubious companies, among many aiming to cash in on coronavirus antibody tests.”

According to the lawsuit, the article contained numerous false and misleading statements about Vivera and its COVID-19 antibody tests. The article is a disparaging hit piece against CEO Paul Edalat. The reporters personally attacked Edalat with false claims about his character, business dealings and ongoing litigation.

USA Today chose to publish false information about the accuracy rates of Vivera’s COVID-19 antibody tests, misleading readers by taking quotes out of context in order to make it appear as though Vivera was hiding information from the public. Vivera has always been transparent about its two COVID-19 antibody test kits and published the validation results of those tests on its website.

On June 3, 2020, one day after the article was published, Vivera, through its legal counsel, delivered a letter to USA Today specifying the false and misleading statements and demanded that USA Today issue a retraction.

Seven days later on June 10, 2020, USA Today’s parent company, Gannett Media refused to retract the article or remove or correct any false and misleading statements about Vivera. The paper did, however, change the title of the article to “Inexperienced, dubious companies on FDA list to sell coronavirus antibody tests.”

“It is unfortunate that Gannett, and USA Today, chose to knowingly print false, misleading, and disparaging comments about myself and Vivera,” said Paul Edalat, CEO of Vivera Pharmaceuticals. “We provided USA Today an opportunity to retract this article, which they refused. This article has nothing to do with the quality of Vivera’s antibody tests and was a coordinated attack on me in an effort to disparage Vivera.”

Vivera has filed suit in the United States District Court, Central District of California.

About Vivera Pharmaceuticals
Vivera Pharmaceuticals, Inc. is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications.  In addition to its pharmaceutical and medical device products, the company has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. The company is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.

CONTACT:
Adam Sechrist for Vivera Pharmaceuticals
media@viverapharma.com

Vivera Pharmaceuticals, Inc. Logo